Related Experiment Video
Updated: Mar 11, 2026
06:08
A Novel Method: Super-selective Adrenal Venous Sampling
Published on: September 15, 2017
24.4K
PRKACA Mutations in Adrenal Adenomas: Genotype/Phenotype Correlations
1Medizinische Klinik und Poliklinik IV, Klinikum der Universität München, München, Germany.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme
|November 22, 2016
Summary
Somatic mutations in the PRKACA gene are common in cortisol-producing adenomas. These genetic changes lead to a more severe disease, impacting adrenal gland function.
Area of Science:
- Endocrinology
- Genetics
- Molecular Biology
Background:
- Next-generation sequencing reveals genetic alterations in adrenal cortex steroidogenesis.
- Somatic mutations in PRKACA are frequently identified in cortisol-producing adenomas.
Purpose of the Study:
- To investigate the role of PRKACA mutations in adrenal adenoma development.
- To correlate PRKACA genotypes with clinical phenotypes of cortisol over-secretion.
Main Methods:
- Utilized untargeted next-generation sequencing to identify genetic mutations.
- Conducted functional studies to understand molecular consequences.
- Analyzed large international cohorts for genotype-phenotype correlations.
Main Results:
- PRKACA mutations are highly specific to cortisol over-secretion and rare in other adrenal diseases.
- Patients with PRKACA mutations exhibit a more severe phenotype.
- Individuals with these mutations are diagnosed at a younger age.
Conclusions:
- PRKACA mutations are a key driver of cortisol-producing adenomas.
- PKA-dependent pathways are crucial for adrenal physiology and disease pathogenesis.
- Genotype-phenotype correlations highlight the clinical significance of PRKACA mutations.
Related Concept Videos
02:38The Ras Gene
7.4K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
Ras is a...
7.4K
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
61
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
61
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
81
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
81
02:07Tumor Progression
7.7K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.7K
01:33Cancer-Critical Genes I: Proto-oncogenes
11.7K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
11.7K
02:23Abnormal Proliferation
5.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K